Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. This observational study is aimed to reflect the
post-authorisation experience with insulin analogue (biphasic insulin aspart 30) when used
under normal clinical practice conditions in Serbia.